Literature DB >> 12055131

Effects of the prostanoids on the proliferation or hypertrophy of cultured murine aortic smooth muscle cells.

Takayuki Fujino1, Koh-ichi Yuhki, Takehiro Yamada, Akiyoshi Hara, Osamu Takahata, Yuji Okada, Chun-Yang Xiao, Hong Ma, Hideji Karibe, Yasunori Iwashima, Jun Fukuzawa, Naoyuki Hasebe, Kenjiro Kikuchi, Shuh Narumiya, Fumitaka Ushikubi.   

Abstract

Effects of the prostanoids on the growth of cultured aortic vascular smooth muscle cells (VSMCs) were examined using mice lacking prostanoid receptors. Proliferation of VSMCs was assessed by measuring [(3)H]-thymidine incorporation and the cell number, and their hypertrophy by [(14)C]-leucine incorporation and protein content. In VSMCs from wild-type mice, expressions of mRNAs for the EP(4) and TP were most abundant, followed by those for the IP, EP(3) and FP, when examined by competitive reverse transcriptase-PCR. Those for the EP(1), EP(2) and DP, however, could not be detected. AE1-329, an EP(4) agonist, and cicaprost, an IP agonist, inhibited platelet derived growth factor (PDGF)-induced proliferation of VSMCs from wild-type mice; these inhibitory effects disappeared completely in VSMCs from EP(4)(-/-) and IP(-/-) mice, respectively. In accordance with these effects, AE1-329 and cicaprost stimulated cAMP production in VSMCs from wild-type mice, which were absent in VSMCs from EP(4)(-/-) and IP(-/-) mice, respectively. Effects of PGE(2) on cell proliferation and adenylate cyclase were almost similar with those of AE1-329 in VSMCs from wild-type mice, which disappeared in VSMCs from EP(4)(-/-) mice. PGD(2) inhibited PDGF-induced proliferation of VSMCs from both wild-type and DP(-/-) mice to a similar extent. This action of PGD(2) was also observed in VSMCs from EP4(-/-) and IP(-/-) mice. In VSMCs from wild-type mice, I-BOP, a TP agonist, showed potentiation of PDGF-induced hypertrophy. I-BOP failed to show this action in VSMCs from TP(-/-) mice. The specific agonists for the EP(1), EP(2) or EP(3), and PGF(2)alpha showed little effect on the growth of VSMCs. These results show that PGE(2), PGI(2) and TXA(2) modulate PDGF-induced proliferation or hypertrophy of VSMCs via the EP(4), IP and TP, respectively, and that the inhibitory effect of PGD(2) on PDGF-induced proliferation is not mediated by the DP, EP(4) or IP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12055131      PMCID: PMC1573378          DOI: 10.1038/sj.bjp.0704749

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  50 in total

1.  The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs.

Authors:  M Abramovitz; M Adam; Y Boie; M Carrière; D Denis; C Godbout; S Lamontagne; C Rochette; N Sawyer; N M Tremblay; M Belley; M Gallant; C Dufresne; Y Gareau; R Ruel; H Juteau; M Labelle; N Ouimet; K M Metters
Journal:  Biochim Biophys Acta       Date:  2000-01-17

2.  Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery.

Authors:  Lucie H Clapp; Paul Finney; Sally Turcato; Sandy Tran; Lewis J Rubin; Andrew Tinker
Journal:  Am J Respir Cell Mol Biol       Date:  2002-02       Impact factor: 6.914

3.  The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs.

Authors:  T Suzawa; C Miyaura; M Inada; T Maruyama; Y Sugimoto; F Ushikubi; A Ichikawa; S Narumiya; T Suda
Journal:  Endocrinology       Date:  2000-04       Impact factor: 4.736

4.  Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells.

Authors:  S Wakino; U Kintscher; S Kim; F Yin; W A Hsueh; R E Law
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

5.  Autonomous and growth factor-induced hypertrophy in cultured neonatal mouse cardiac myocytes. Comparison with rat.

Authors:  X F Deng; D G Rokosh; P C Simpson
Journal:  Circ Res       Date:  2000-10-27       Impact factor: 17.367

6.  Increased bleeding tendency and decreased susceptibility to thromboembolism in mice lacking the prostaglandin E receptor subtype EP(3).

Authors:  H Ma; A Hara; C Y Xiao; Y Okada; O Takahata; K Nakaya; Y Sugimoto; A Ichikawa; S Narumiya; F Ushikubi
Journal:  Circulation       Date:  2001-09-04       Impact factor: 29.690

7.  Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells.

Authors:  J Wharton; N Davie; P D Upton; M H Yacoub; J M Polak; N W Morrell
Journal:  Circulation       Date:  2000-12-19       Impact factor: 29.690

8.  Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2).

Authors:  H Hizaki; E Segi; Y Sugimoto; M Hirose; T Saji; F Ushikubi; T Matsuoka; Y Noda; T Tanaka; N Yoshida; S Narumiya; A Ichikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

9.  Characterization of G-protein signaling in ventricular myocytes from the adult mouse heart: differences from the rat.

Authors:  R Hilal-Dandan; J R Kanter; L L Brunton
Journal:  J Mol Cell Cardiol       Date:  2000-07       Impact factor: 5.000

10.  Characterization of prostanoid receptors mediating contraction of the gastric fundus and ileum: studies using mice deficient in prostanoid receptors.

Authors:  Y Okada; A Hara; H Ma; C Y Xiao; O Takahata; Y Kohgo; S Narumiya; F Ushikubi
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

View more
  9 in total

1.  Differential regulation of vascular tone and remodeling via stimulation of type 2 and type 6 adenylyl cyclases in the ductus arteriosus.

Authors:  Utako Yokoyama; Susumu Minamisawa; Ayako Katayama; Tong Tang; Sayaka Suzuki; Kousaku Iwatsubo; Shiho Iwasaki; Reiko Kurotani; Satoshi Okumura; Motohiko Sato; Shumpei Yokota; H Kirk Hammond; Yoshihiro Ishikawa
Journal:  Circ Res       Date:  2010-04-29       Impact factor: 17.367

2.  PGE2 through the EP4 receptor controls smooth muscle gene expression patterns in the ductus arteriosus critical for remodeling at birth.

Authors:  Artiom Gruzdev; MyTrang Nguyen; Martina Kovarova; Beverly H Koller
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-02-11       Impact factor: 3.072

Review 3.  Transcriptional profiling of the ductus arteriosus: Comparison of rodent microarrays and human RNA sequencing.

Authors:  Michael T Yarboro; Matthew D Durbin; Jennifer L Herington; Elaine L Shelton; Tao Zhang; Cris G Ebby; Jason Z Stoller; Ronald I Clyman; Jeff Reese
Journal:  Semin Perinatol       Date:  2018-05-10       Impact factor: 3.300

4.  Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus.

Authors:  Utako Yokoyama; Susumu Minamisawa; Hong Quan; Shibnath Ghatak; Toru Akaike; Eri Segi-Nishida; Shiho Iwasaki; Mari Iwamoto; Suniti Misra; Kouichi Tamura; Hideaki Hori; Shumpei Yokota; Bryan P Toole; Yukihiko Sugimoto; Yoshihiro Ishikawa
Journal:  J Clin Invest       Date:  2006-11       Impact factor: 14.808

5.  Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice.

Authors:  Takuya Kobayashi; Yoshio Tahara; Mayumi Matsumoto; Masako Iguchi; Hideto Sano; Toshinori Murayama; Hidenori Arai; Hiroji Oida; Takami Yurugi-Kobayashi; Jun K Yamashita; Hiroyuki Katagiri; Masataka Majima; Masayuki Yokode; Toru Kita; Shuh Narumiya
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

6.  Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP.

Authors:  Takayuki Fujino; Naoki Nakagawa; Koh-Ichi Yuhki; Akiyoshi Hara; Takehiro Yamada; Koji Takayama; Shuhko Kuriyama; Yayoi Hosoki; Osamu Takahata; Takanobu Taniguchi; Jun Fukuzawa; Naoyuki Hasebe; Kenjiro Kikuchi; Shuh Narumiya; Fumitaka Ushikubi
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

7.  Vascular smooth muscle cell calcification and SLC20 inorganic phosphate transporters: effects of PDGF, TNF-alpha, and Pi.

Authors:  Ricardo Villa-Bellosta; Moshe Levi; Victor Sorribas
Journal:  Pflugers Arch       Date:  2009-06-09       Impact factor: 3.657

8.  Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction.

Authors:  Jian-Yong Qian; Pamela Harding; Yunhe Liu; Ed Shesely; Xiao-Ping Yang; Margot C LaPointe
Journal:  Hypertension       Date:  2008-01-07       Impact factor: 10.190

9.  Acyl chain-dependent effect of lysophosphatidylcholine on endothelium-dependent vasorelaxation.

Authors:  Shailaja P Rao; Monika Riederer; Margarete Lechleitner; Martin Hermansson; Gernot Desoye; Seth Hallström; Wolfgang F Graier; Saša Frank
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.